| Tumor suppressor gene p16/INK4A/CDKN2A‐dependent regulation into and out of the cell cycle in a spontaneous canine model of breast cancer P Agarwal, M Sandey, P DeInnocentes, RC Bird Journal of cellular biochemistry 114 (6), 1355-1363, 2013 | 53 | 2013 |
| Phenotype‐rescue of cyclin‐dependent kinase inhibitor p16/INK4A defects in a spontaneous canine cell model of breast cancer P DeInnocentes, P Agarwal, RC Bird Journal of cellular biochemistry 106 (3), 491-505, 2009 | 38 | 2009 |
| Tumor suppressor gene p16/INK4A/CDKN2A and its role in cell cycle exit, differentiation, and determination of cell fate P Agarwal, FML Kabir, P DeInnocentes, RC Bird Tumor suppressor genes 10, 27882, 2012 | 33 | 2012 |
| miRNAs: Potential as biomarkers and therapeutic targets for cancer A Chakrabortty, DJ Patton, BF Smith, P Agarwal Genes 14 (7), 1375, 2023 | 29 | 2023 |
| Estrogen receptor-α, progesterone receptor, and c-erbB/HER-family receptor mRNA detection and phenotype analysis in spontaneous canine models of breast cancer FML Kabir, P DeInnocentes, P Agarwal, CP Mill, DJ Riese 2nd, RC Bird Journal of veterinary science 18 (2), 149, 2017 | 25 | 2017 |
| Novel frameshift mutation in the p16/INK4A tumor suppressor gene in canine breast cancer alters expression from the p16/INK4A/p14ARF locus FM Lutful Kabir, P Agarwal, P DeInnocentes, J Zaman, AC Bird, RC Bird Journal of Cellular Biochemistry 114 (1), 56-66, 2013 | 22 | 2013 |
| Cell-surface integrins and CAR are both essential for adenovirus type 5 transduction of canine cells of lymphocytic origin P Agarwal, EA Gammon, AM Sajib, M Sandey, BF Smith PLoS One 12 (1), e0169532, 2017 | 15 | 2017 |
| Nanobody-based CTLA4 inhibitors for immune checkpoint blockade therapy of canine cancer patients J Marable, D Ruiz, AK Jaiswal, R Bhattacharya, R Pantazes, P Agarwal, ... Scientific Reports 11 (1), 20763, 2021 | 13 | 2021 |
| Identification of canine circulating miRNAs as tumor biospecific markers using Next-Generation Sequencing and Q-RT-PCR P Agarwal, MP Crepps, NA Stahr, WP Kretzschmar, HC Harris, N Prasad, ... Biochemistry and biophysics reports 28, 101106, 2021 | 11 | 2021 |
| Transcriptomic analysis of canine osteosarcoma from a precision medicine perspective reveals limitations of differential gene expression studies RL Nance, SJ Cooper, D Starenki, X Wang, B Matz, S Lindley, AN Smith, ... Genes 13 (4), 680, 2022 | 6 | 2022 |
| A method for isolating RNA from canine bone R Nance, P Agarwal, M Sandey, D Starenki, J Koehler, AM Sajib, ... Biotechniques 68 (6), 311-317, 2020 | 6 | 2020 |
| Evaluation of tumor immunity after administration of conditionally replicative adenoviral vector in canine osteosarcoma patients P Agarwal, EA Gammon, M Sandey, SS Lindley, JW Koehler, BM Matz, ... Heliyon 7 (2), 2021 | 5 | 2021 |
| Development of OX40 agonists for canine cancer immunotherapy D Ruiz, C Haynes, J Marable, C Pundkar, RL Nance, D Bedi, P Agarwal, ... Iscience 25 (10), 2022 | 3 | 2022 |
| In vitro functional genetic modification of canine adenovirus type 2 genome by CRISPR/Cas9 AM Sajib, P Agarwal, DJ Patton, RL Nance, NA Stahr, WP Kretzschmar, ... Laboratory Investigation 101 (12), 1627-1636, 2021 | 3 | 2021 |
| Evaluation of 14-3-3 sigma as a potential partner of p16 in quiescence and differentiation P Agarwal, P DeInnocentes, RC Bird In Vitro Cellular & Developmental Biology-Animal 54, 658-665, 2018 | 3 | 2018 |
| Analysis of endogenous and exogenous tumor upregulated promoter expression in canine tumors AM Sajib, M Sandey, S Morici, B Schuler, P Agarwal, BF Smith Plos one 15 (11), e0240807, 2020 | 1 | 2020 |
| Bridging the gaps: A cross-species approach to PD-1 and OX40 combination immunotherapy M Sandey, D Ruiz, J Marable, D Bedi, P Agarwal Cancer Research 84 (6_Supplement), 3736-3736, 2024 | | 2024 |
| The Development and Characterization of a Next-Generation Oncolytic Virus Armed with an Anti-PD-1 sdAb for Osteosarcoma Treatment In Vitro TA Higgins, DJ Patton, IM Shimko-Lofano, TL Eller, R Molinari, M Sandey, ... Cells 13 (4), 351, 2024 | | 2024 |
| Exploration of multiple immunotherapy modalities in ostesarcoma AA Ismail, DJ Patton, TA Higgins, M Sandey, BF Smith, P Agarwal Cancer Research 83 (7_Supplement), 2339-2339, 2023 | | 2023 |
| Abstract A039: Transcriptomic analysis of canine osteosarcoma from a precision medicine perspective reveals limitations of differential gene expression studies RL Nance, S Cooper, D Starenki, X Wang, M Sandey, J Koehler, ... Cancer Research 82 (10_Supplement), A039-A039, 2022 | | 2022 |
Maninder SandeyAssistant Professor, Auburn University在 auburn.edu 的电子邮件经过验证
